Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas

被引:28
作者
Grützmann, R
Pilarsky, C
Staub, E
Schmitt, AO
Foerder, M
Specht, T
Hinzmann, B
Dahl, E
Alldinger, I
Rosenthal, A
Ockert, D
Saeger, HD
机构
[1] Univ Clin Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, D-01307 Dresden, Germany
[2] metaGen Pharmaceut, Berlin, Germany
关键词
pancreatic cancer; gene; expression profiling;
D O I
10.1159/000070087
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: There is increasing knowledge about the genetic basis of pancreatic cancer (PaCa). Tumor suppressor genes (TSGs; e.g. p53 and DPC4) and oncogenes (e.g. K-ras) have been shown to be involved in the development of PaCa. However, the extent of chromosomal changes (gains and losses) implicates that many more genes may be involved in the multistep progression of PaCa. Identification of these genes is essential for understanding the molecular events in the development of PaCa. Methods: We assembled public and proprietary libraries of more than 4 million expressed sequence tags using newly developed software tools. Results: We identified a total of 249 genes with specific expression patterns in normal and cancerous tissue of the pancreas. Of these, 27 genes were found to be preferentially expressed in normal tissue of the pancreas, while 222 genes showed significant upregulation of expression in PaCa. Of the 249 genes, 232 (93.2%) were found to represent known human genes or putative human homologues of genes characterized previously in other species, while 17 (6.8%) represent putative new genes. Conclusion: These genes may represent a valuable source to identify novel TSGs and oncogenes involved in the carcinogenesis of PaCa. Copyright (C) 2003 S. Karger AG, Basel and IAP.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 39 条
[1]   COMPLEMENTARY-DNA SEQUENCING - EXPRESSED SEQUENCE TAGS AND HUMAN GENOME PROJECT [J].
ADAMS, MD ;
KELLEY, JM ;
GOCAYNE, JD ;
DUBNICK, M ;
POLYMEROPOULOS, MH ;
XIAO, H ;
MERRIL, CR ;
WU, A ;
OLDE, B ;
MORENO, RF ;
KERLAVAGE, AR ;
MCCOMBIE, WR ;
VENTER, JC .
SCIENCE, 1991, 252 (5013) :1651-1656
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
Argani P, 2001, CLIN CANCER RES, V7, P3862
[4]   KARYOTYPIC ABNORMALITIES IN TUMORS OF THE PANCREAS [J].
BARDI, G ;
JOHANSSON, B ;
PANDIS, N ;
MANDAHL, N ;
BAKJENSEN, E ;
ANDRENSANDBERG, A ;
MITELMAN, F ;
HEIM, S .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1106-1112
[5]   ABNORMALITIES OF THE P53 TUMOR SUPPRESSOR GENE IN HUMAN PANCREATIC-CANCER [J].
BARTON, CM ;
STADDON, SL ;
HUGHES, CM ;
HALL, PA ;
OSULLIVAN, C ;
KLOPPEL, G ;
THEIS, B ;
RUSSELL, RCG ;
NEOPTOLEMOS, J ;
WILLIAMSON, RCN ;
LANE, DP ;
LEMOINE, NR .
BRITISH JOURNAL OF CANCER, 1991, 64 (06) :1076-1082
[6]   Isolation of a novel beta(4) integrin-binding protein (p27(BBP)) expressed in epithelial cells [J].
Biffo, S ;
Sanvito, F ;
Costa, S ;
Preve, L ;
Pignatelli, R ;
Spinardi, L ;
Marchisio, PC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30314-30321
[7]  
Brat DJ, 1997, AM J PATHOL, V150, P383
[8]   P53 MUTATIONS ARE COMMON IN PANCREATIC-CANCER AND ARE ABSENT IN CHRONIC-PANCREATITIS [J].
CASEY, G ;
YAMANAKA, Y ;
FRIESS, H ;
KOBRIN, MS ;
LOPEZ, ME ;
BUCHLER, M ;
BEGER, HG ;
KORC, M .
CANCER LETTERS, 1993, 69 (03) :151-160
[9]  
CLEMMONS DR, 1993, ANN NY ACAD SCI, V692, P10
[10]   Gene expression in normal and disease states - Identification of therapeutic targets [J].
Fannon, MR .
TRENDS IN BIOTECHNOLOGY, 1996, 14 (08) :294-298